Literature DB >> 16597861

Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli.

Owen D Solberg1, Remi M Ajiboye, Lee W Riley.   

Abstract

The prevalence of urinary tract infections (UTI) caused by trimethoprim-sulfamethoxazole (TMP-SMX)-resistant Escherichia coli is increasing and varies geographically in the United States. Recent community-based UTI studies have demonstrated geographic clustering of an Escherichia coli clonal group, suggesting occurrence of a community outbreak of UTI. A large proportion of this clonal group (designated CgA) isolated from women in a California college community was found to be resistant to TMP-SMX. We wished to determine if the acquisition of TMP-SMX resistance by CgA occurred before or after the CgA strains were introduced into this community. Between October 1999 and January 2000 and between October 2000 and January 2001, 482 E. coli isolates were consecutively collected from the urine samples of women with UTI at a student health clinic and analyzed for determinants of TMP-SMX resistance. In particular, the distribution of integrons harboring resistance cassettes for TMP-SMX (dfr) was examined. Among 95 TMP-SMX-resistant isolates, 68 and 27 isolates carried class 1 and class 2 integrons, respectively. A class 1 integron was found in 25 (93%) of 27 TMP-SMX-resistant CgA isolates but in only 43 (63%) of 68 TMP-SMX-resistant non-CgA isolates (P < 0.001) and in none of 44 TMP-SMX-susceptible E. coli isolates (P < 0.0001). CgA strains carried only a single arrangement of class 1 gene cassettes (dfrA17-aadA5), while the non-clonal group strains carried nine different cassette arrangements. These results support the idea that CgA strains acquired their resistance at a common site prior to their spread to the college community.

Entities:  

Mesh:

Year:  2006        PMID: 16597861      PMCID: PMC1448660          DOI: 10.1128/JCM.44.4.1347-1351.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Current status of the aadA and dfr gene cassette families.

Authors:  P A White; W D Rawlinson
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

2.  Two new gene cassettes, dfr17 (for trimethoprim resistance) and aadA4 (for spectinomycin/streptomycin resistance), inserted in an Escherichia coli class 1 integron.

Authors:  C Y Chang; L L Chang; Y H Chang; T M Lee; Y H Li; S F Chang
Journal:  J Antimicrob Chemother       Date:  2000-07       Impact factor: 5.790

3.  Integrons and gene cassettes in the enterobacteriaceae.

Authors:  P A White; C J McIver; W D Rawlinson
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

4.  Improved repetitive-element PCR fingerprinting for resolving pathogenic and nonpathogenic phylogenetic groups within Escherichia coli.

Authors:  J R Johnson; T T O'Bryan
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

5.  Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli.

Authors:  Anne Marie France; Kiersten M Kugeler; Alison Freeman; Christy Ann Zalewski; Matthew Blahna; Lixin Zhang; Carl F Marrs; Betsy Foxman
Journal:  Clin Infect Dis       Date:  2005-03-15       Impact factor: 9.079

6.  Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing.

Authors:  Sara Y Tartof; Owen D Solberg; Amee R Manges; Lee W Riley
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

7.  Incidence of class 1 and 2 integrases in clinical and commensal bacteria from livestock, companion animals, and exotics.

Authors:  C Goldstein; M D Lee; S Sanchez; C Hudson; B Phillips; B Register; M Grady; C Liebert; A O Summers; D G White; J J Maurer
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

8.  Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.

Authors:  A R Manges; J R Johnson; B Foxman; T T O'Bryan; K E Fullerton; L W Riley
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

9.  Urologic diseases in America project: trends in resource use for urinary tract infections in women.

Authors:  Tomas L Griebling
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

10.  The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections.

Authors:  A R Manges; P Natarajan; O D Solberg; P S Dietrich; L W Riley
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

View more
  23 in total

1.  Population structure and resistance genes in antibiotic-resistant bacteria from a remote community with minimal antibiotic exposure.

Authors:  Lucia Pallecchi; Chiara Lucchetti; Alessandro Bartoloni; Filippo Bartalesi; Antonia Mantella; Herlan Gamboa; Alessandra Carattoli; Franco Paradisi; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Class 1 and class 2 integrons and plasmid-mediated antibiotic resistance in coliforms isolated from ten rivers in northern Turkey.

Authors:  Osman Birol Ozgumus; Cemal Sandalli; Ali Sevim; Elif Celik-Sevim; Nuket Sivri
Journal:  J Microbiol       Date:  2009-02-20       Impact factor: 3.422

3.  Preservation of integron types among Enterobacteriaceae producing extended-spectrum beta-lactamases in a Spanish hospital over a 15-year period (1988 to 2003).

Authors:  Elisabete Machado; Joana Ferreira; Angela Novais; Luísa Peixe; Rafael Cantón; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

4.  Globally dispersed mobile drug-resistance genes in gram-negative bacterial isolates from patients with bloodstream infections in a US urban general hospital.

Authors:  S Adams-Sapper; J Sergeevna-Selezneva; S Tartof; E Raphael; B An Diep; F Perdreau-Remington; L W Riley
Journal:  J Med Microbiol       Date:  2012-04-05       Impact factor: 2.472

5.  Multilocus sequence typing of uropathogenic ESBL-producing Escherichia coli isolated in a Brazilian community.

Authors:  Luciene A R Minarini; Ilana L B C Camargo; André Pitondo-Silva; Ana Lúcia C Darini
Journal:  Curr Microbiol       Date:  2007-09-25       Impact factor: 2.188

6.  Recovery of a functional class 2 integron from an Escherichia coli strain mediating a urinary tract infection.

Authors:  Carolina Márquez; Maurizio Labbate; Ana J Ingold; Piklu Roy Chowdhury; Maria S Ramírez; Daniela Centrón; Graciela Borthagaray; H W Stokes
Journal:  Antimicrob Agents Chemother       Date:  2008-09-15       Impact factor: 5.191

7.  Antimicrobial resistance and prevalence of canine uropathogens at the Western College of Veterinary Medicine Veterinary Teaching Hospital, 2002-2007.

Authors:  Katherine R Ball; Joseph E Rubin; M Chirino-Trejo; Patricia M Dowling
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

8.  Urinary tract infections in a South American population: dynamic spread of class 1 integrons and multidrug resistance by homologous and site-specific recombination.

Authors:  Carolina Márquez; Maurizio Labbate; Claudia Raymondo; Jimena Fernández; Alicia M Gestal; Marita Holley; Graciela Borthagaray; H W Stokes
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

9.  Identification of antibiotic resistance cassettes in class 1 integrons in Aeromonas spp. strains isolated from fresh fish (Cyprinus carpio L.).

Authors:  Yohanna Sarria-Guzmán; María Patricia López-Ramírez; Yosef Chávez-Romero; Erick Ruiz-Romero; Luc Dendooven; Juan Manuel Bello-López
Journal:  Curr Microbiol       Date:  2013-12-27       Impact factor: 2.188

10.  Detection of Antimicrobial Susceptibility and Integrons Among Extended-spectrum β-lactamase Producing Uropathogenic Escherichia coli Isolates in Southwestern Iran.

Authors:  Hadi Sedigh Ebrahim-Saraie; Niloofar Zahedian Nezhad; Hamid Heidari; Ashkan Motamedifar; Mohammad Motamedifar
Journal:  Oman Med J       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.